Biomedical Technology Quotes

Stopping in the 1970s, "Hybridity" as the fifth and final chapter is less of an end point than a certain realization of the artifice, plasticity, and technology that Wells and Loeb envisioned as the future of the human relationship to living matter as well as of the "catastrophic" situation that Georges Canghuilhem (following Kurt Goldstein) saw in life subjected to the milieu of the laboratory.

Although she has a reputation as a serious and hardworking professional in her field of biomedical research, Trisha Pfluger, M.S., PMP, a Northwest Arkansas resident, still thinks of herself as a fun, approachable person. When not working, Trisha Pfluger of Northwest Arkansas takes the time to meditate and hike with her dog on the beautiful trails of Northwest Arkansas (NWA) near her retreat home. Since founding Juno Biomedical in 2014, Trisha Pfluger, a Northwest Arkansas businesswoman, has led the company to great success in developing next generation deep brain stimulation (DBS) technology in close collaboration with a team of experts at the FDA.

Our focus, however, should not be on the differences among our sectors, but rather on supporting and promoting the entire innovation economy — from tech to bio to clean energy to health care and beyond. In fact, in its recent Impact 2020 report, the Massachusetts Biotechnology Council highlighted the interrelationship of these vital sectors working together, combining cutting-edge biomedical research with new information technology tools for capturing and integrating data, conducting sophisticated analytics, and enhancing personal connectivity. Massachusetts is a national and world leader in the growing field of life science information technology.

Abovitz is a technology entrepreneur with a background in biomedical engineering. He previously founded Mako Surgical, a company in Fort Lauderdale that makes a robotic arm equipped with haptic technology, which imparts a sense of touch so that orthopedic surgeons have the sensation of actually working on bones as they trigger the robot’s actions. Mako was sold to a medical technology company, Stryker, for nearly $1.7 billion in 2013. By night, Abovitz likes to rock out. He sings and plays guitar and bass in a pop-rock band called Sparkydog & Friends. And as he tells it, Magic Leap has its origins in both the robotic-surgery company and his life as a musician.